What Is Endotech AI?
Endotech is not a retail trading script. It is a highly sophisticated, self-adaptive artificial intelligence firm founded in 2012 by Dr. Anna Becker — a PhD in Computer Science and AI from the Technion Institute of Technology, Israel's equivalent of MIT. With over three decades of quantitative finance experience, co-authorship of a book on Bayesian networks, and a previous fintech exit with Strategy Runner, Dr. Becker brings institutional credentials that most crypto project founders cannot approach.
With over $40 million deployed into deep-learning infrastructure over five years and a team of 40+ quantitative scientists, Endotech was originally designed strictly for hedge funds and high-net-worth institutional players with minimum investments starting at $50,000. Thanks to an exclusive partnership with Bit1 Exchange and the Limitless IB Portal, everyday investors can now connect directly to the Endotech Alpha strategies with no minimum deposit and full API custody.
The Statistical Edge
Historical live deployment of the Endotech Alpha algorithms shows an 83% win rate across all trades — meaning 8 out of 10 positions close profitably. Critically, winning trades are consistently larger in size than losing trades, producing the asymmetric return profile that defines professional algorithmic systems.
Full 8-Year Performance Data
Claims are cheap in the crypto industry. Here is what 8 years of live operation actually produced. All figures use fixed capital calculation — the same base amount trades every cycle regardless of prior profits. This is the most conservative reporting method and gives the clearest comparison baseline.